Faes Farma SA FFEA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €4.54
- Day Range
- €4.67–4.67
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 311.45M
- Market Cap
- €1.45B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 17.14
- Price/Sales
- 2.10
- Dividend Yield (Trailing)
- 2.74%
- Dividend Yield (Forward)
- 2.74%
- Dividend Payment Schedule
- Jan, Jul
- Total Yield
- 2.74%
Company Profile
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,611
- Website
- http://faesfarma.com
Valuation
|
Metric
|
FFEA
|
|---|---|
Price/Earnings (Normalized) | 17.14 |
Price/Book Value | 1.88 |
Price/Sales | 2.10 |
Price/Cash Flow | 12.64 |
Price/Earnings
FFEA
Financial Strength
|
Metric
|
FFEA
|
|---|---|
Quick Ratio | 1.66 |
Current Ratio | 2.63 |
Interest Coverage | 8.96 |
Quick Ratio
FFEA
Profitability
|
Metric
|
FFEA
|
|---|---|
Return on Assets (Normalized) | 6.81% |
Return on Equity (Normalized) | 11.46% |
Return on Invested Capital (Normalized) | 8.88% |
Return on Assets
FFEA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|s$#J$D! | LOCK|>!m%$ | $68B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|>^b@lYPY | LOCK|>$sg# | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|rZM&#&# | LOCK|f$ | $40B | |||
| Zoetis Inc Class A
ZTS
| LOCK|LC$<<qK& | LOCK|tQ | $30B | |||
| Viatris Inc
VTRS
| LOCK|cRxF^> | LOCK|Ynb | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|y> | LOCK|jQV | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|%?B&>? | LOCK|%% | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|@&YXB& | LOCK|^@ | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|xr>>z>? | LOCK|?#k$< | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|qxMLkDV | LOCK|mgt | $2B |
United States